Skip to Main Content

Author Details

Thomas Hauser
Kepler University Hospital, Johannes Kepler University
1994
35
17
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36617233Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis.Nephrol Dial Transplant2023
37002990Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level.EBioMedicine2023
35303173Frequency and characteristics of bacterial and viral low-grade infections of the intervertebral discs: a prospective, observational study.J Orthop Traumatol2022
35967106The Sound of Interconnectivity; The European Vasculitis Society 2022 Report.Kidney Int Rep2022
36130476SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern.EBioMedicine2022
35244174Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS.Nephrol Dial Transplant2022
31271267[18F]fluorodeoxyglucose-positron emission tomography and glucose-transporter type 1 expression in untreated primary small bowel adenocarcinoma.Q J Nucl Med Mol Imaging2021
34843493Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches.PLoS One2021
34619377Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors.Clin Immunol2021
31044336Ficolin-3 Deficiency Is Associated with Disease and an Increased Risk of Systemic Lupus Erythematosus.J Clin Immunol2019
29364894Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus.PLoS One2018
30150718The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.Nat Med2018
28955487Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts.RMD Open2017
29634043The European Vasculitis Society 2016 Meeting Report.Kidney Int Rep2017
27338776EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.Ann Rheum Dis2016
25739829Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.Ann Rheum Dis2015
25753806B-cell therapy in antineutrophil cytoplasmic antibody-associated vasculitis.Nephrol Dial Transplant2015
25115978The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland.Swiss Med Wkly2014
22640651Alveolar haemorrhage in ANCA-associated vasculitides: 80 patients' features and prognostic factors.Clin Exp Rheumatol2012
22681738Coiling after treatment with the woven EndoBridge cerebral aneurysm embolization device. A case report.Interv Neuroradiol2012
19574233Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis.Ann Rheum Dis2010
21060104Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.JAMA2010
20809449Long-term angiographic and histological results of a new hydrogel-containing filling coil in experimental rabbit aneurysms.Minim Invasive Neurosurg2010
20448283EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis.Ann Rheum Dis2010
20647198Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.N Engl J Med2010
18413441EULAR recommendations for the management of large vessel vasculitis.Ann Rheum Dis2009
19441745[Towards the Swiss systemic lupus erythematosus cohort study (SSCS)].Rev Med Suisse2009
19290469Comparison of experimental aneurysms embolized with second-generation embolic devices and platinum coils.Acta Neurochir (Wien)2009
18413444EULAR recommendations for the management of primary small and medium vessel vasculitis.Ann Rheum Dis2009
18276721The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study.Thorax2008
16901958Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.Ann Rheum Dis2007
15340881Montelukast and Churg-Strauss syndrome.Swiss Med Wkly2004
12800198Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia.Int J Cancer2003
8760277Generation and characterization of a human monoclonal autoantibody that acts as a high affinity interleukin-1 alpha specific inhibitor.Mol Immunol1996
7861042Human monoclonal antibody as an interleukin-10-specific antagonist.J Interferon Res1994
  • 1 - 35 of 35

Recommended Authors

University of California san francisco
Career Start Year 2014
Number of shared co-authors 0
Institute for Medical Biostatistics, University Medical Center Mainz
Career Start Year 2013
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2012
Number of shared co-authors 0
University of Arizona
Career Start Year 2011
Number of shared co-authors 0
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Career Start Year 2011
Number of shared co-authors 3
University of South Florida
Career Start Year 2010
Number of shared co-authors 0
Mayo Clinic and Foundation
Career Start Year 2010
Number of shared co-authors 1
University Hospital Quironsalud Madrid
Career Start Year 2009
Number of shared co-authors 0
Medical Subspecialities Institute, Cleveland Clinic
Career Start Year 2008
Number of shared co-authors 0
Mayo Clinic Arizona
Career Start Year 2007
Number of shared co-authors 1
Universite Paris-Cite, INSERM
Career Start Year 2006
Number of shared co-authors 0
Massachusetts General Hospital, and Harvard Medical School.
Career Start Year 2005
Number of shared co-authors 1
Toronto Western Hospital, University of Toronto
Career Start Year 2003
Number of shared co-authors 1
Institute of Rheumatology, Charles University
Career Start Year 2003
Number of shared co-authors 0
Hospital Universitario HM Monteprincipe, HM Hospitales
Career Start Year 2002
Number of shared co-authors 0
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Career Start Year 1999
Number of shared co-authors 0
University Health Network
Career Start Year 1998
Number of shared co-authors 0
Tokyo Medical and Dental University
Career Start Year 1998
Number of shared co-authors 0
Peking Union Medical College Hospital (PUMCH)
Career Start Year 1998
Number of shared co-authors 2
Yale University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
Centre Hospitalo-Universitaire de Rouen
Career Start Year 1988
Number of shared co-authors 0
Center for Biologics Evaluation and Research
Career Start Year 1988
Number of shared co-authors 0
Albert Einstein College of Medicine
Career Start Year 1986
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 1986
Number of shared co-authors 0
University of Rochester Medical Center
Career Start Year 1983
Number of shared co-authors 0
Biostatistics & Clinical Trial Center, Fondazione IRCCS Policlinico San Matteo
Career Start Year 1981
Number of shared co-authors 3
the Ohio State University Wexner Medical Center
Career Start Year 1980
Number of shared co-authors 2
University of Toronto
Career Start Year 1976
Number of shared co-authors 0
NYU Grossman School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

University of Pennsylvania Perelman School of Medicine
Co-authored papers 5
Kepler University Hospital, Johannes Kepler University
Co-authored papers 2
Southend Hospital NHS Trust
Co-authored papers 2
Kepler University Hospital
Co-authored papers 2
Medical Clinic and Policlinic IV, University of Munich
Co-authored papers 2
Christian Doppler University Hospital, Paracelsus Medical University
Co-authored papers 1
University of Virginia
Co-authored papers 1
Johannes Kepler University
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
Medical University of Vienna
Co-authored papers 1
Medical University of Vienna
Co-authored papers 1
Medical University of Innsbruck
Co-authored papers 1
Medical University of Vienna
Co-authored papers 1
Medical University of Innsbruck
Co-authored papers 1
Indiana University School of Medicine
Co-authored papers 1
Medical University of Vienna, Center for Medical Physics and Biomedical Engineering
Co-authored papers 1
Medical University of Innsbruck
Co-authored papers 1
Medical University of Innsbruck
Co-authored papers 1
University Hospital of the Ludwig Maximilians University Munich
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
Institute of Pathology, State Hospital Klagenfurt
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
Leibniz-Institut fuer Wissensmedien
Co-authored papers 1
Karl Landsteiner University of Health Sciences
Co-authored papers 1
Medical University of Vienna
Co-authored papers 1
Medical University of Innsbruck
Co-authored papers 1
Center for Medical Physics and Biomedical Engineering, Medical University of Vienna
Co-authored papers 1
Medical University of Vienna
Co-authored papers 1
Medical University Innsbruck
Co-authored papers 1
Medical University of Graz
Co-authored papers 1